Table 1.
Disease/Patient no. | Targets identified | Sequence abnormalities |
---|---|---|
All | ||
07-278 | K-RAS, CSF1R | K-RAS G13D |
07-091 | N-RAS | |
07-112 | ROR1 | |
CMML | ||
07-079 | JAK2 | MPL 1886InsGG |
07-172 | EPHA5 | |
CNL | ||
07-214* | JAK2, EPHA4, LYN, LMTK3 | JAK2 V617F |
AML | ||
07-008 | FLT1 | |
07-020 | EPHA4 | |
07-025 | PDGFRα/β, FYN, PTK2B | PDGFRβ V316M |
07-078 | JAK1/3 |
*Not run in triplicate because of limited sample.